Financial News | News | Okategoriserade

Presentation of IDL Diagnostics Interim Report Q4 2025

Mar 2, 2026

CEO Anders Hultman and CFO Ellen Dittberner present the company’s Q4’25 results – February 26, 2026

Q4 Interview: Redeye talks with CEO Anders Hultman

 

 

 

Partnership Meetings and CLIA Focus in China

Mar 20, 2026 | ,

Anders Hultman, Gustav Sten, Xia Jiang and Marie Torstensson have been in Shanghai, China, to meet our partners within CLIA. Currently, we have one product on the market, TPS CLIA, as well as two products in development: TK1 CLIA and UBC CLIA. The purpose of the...

read more

IDL Diagnostics at EAU26

Mar 17, 2026 | ,

IDL Diagnostics attended the European Association of Urology (EAU) 2026 conference in London last week. We had valuable discussions with physicians who use our diagnostic biomarkers in clinical practice and research. A big thank you to everyone we met at EAU26! We...

read more

IDL Diagnostics and concile at WHX Labs Dubai

Feb 20, 2026 | ,

Last week, IDL Diagnostics participated as an exhibitor at WHX Labs Dubai together with concile as part of the recently announced joint venture. The main focus is on delivering multiple biomarkers across different POC reader configurations and supporting infection,...

read more